Exome sequencing identifies a de novo frameshift mutation in the imprinted gene ZDBF2 in a sporadic patient with Nasopalpebral Lipoma-coloboma syndrome

Oscar F. Chacón-Camacho, Nara Sobreira, Jing You, Raul Eduardo Pina Aguilar, Vanessa Villegas-Ruiz, Juan C. Zenteno*

*Corresponding author for this work

Research output: Contribution to journalLetter

2 Citations (Scopus)


Nasopalpebral lipoma-coloboma syndrome (NPLCS, OMIM%167730) is an uncommon malformation entity with autosomal dominant inheritance characterized by the combination of nasopalpebral lipoma, colobomas in upper and lower eyelids, telecanthus, and maxillary hypoplasia. To date, no genetic defects have been associated with familial or sporadic NPLCS cases and the etiology of the disease remains unknown. In this work, the results of whole exome sequencing in a sporadic NPLCS patient are presented. Exome sequencing identified a de novo heterozygous frameshift dinucleotide insertion c.6245_6246 insTT (p.His2082fs*67) in ZDBF2 (zinc finger, DBF-type containing 2), a gene located at 2q33.3. This variant was absent in parental DNA, in a set of 300 ethnically matched controls, and in public exome variant databases. This is the first genetic variant identified in a NPLCS patient and evidence supporting the pathogenicity of the identified mutation is discussed.

Original languageEnglish
Pages (from-to)1934-1937
Number of pages4
JournalAmerican Journal of Medical Genetics. Part A
Issue number7
Early online date3 May 2016
Publication statusPublished - 1 Jul 2016



  • coloboma
  • exome sequencing
  • nasopalpebral lipoma
  • ZDBF2

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this